Evidence map›Paper›PMID 39014977›Full record

ArticleBJU international2025

'Case of the Month' from Addenbrooke's Hospital, Cambridge, UK: surgery after near complete response to combined immunotherapy and tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma with inferior vena cava tumour thrombus.

James P Blackmur, James N Armitage, James O Jones, Antony C P Riddick, Thomas J Mitchell, William H J Ince, Sona Appukutty, Anne Y Warren, Kate Fife, Brent O'Carrigan and 1 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BJU international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

James P BlackmurDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID https://orcid.org/0000-0001-7267-837X
James N ArmitageDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
James O JonesDepartment of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Antony C P RiddickDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Thomas J MitchellDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID https://orcid.org/0000-0003-0761-9503
William H J InceDepartment of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Sona AppukuttyDepartment of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID https://orcid.org/0000-0003-4477-1766
Anne Y WarrenDepartment of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Kate FifeDepartment of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Brent O'CarriganDepartment of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Grant D StewartDepartment of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID https://orcid.org/0000-0003-3188-9140

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cytoreductive nephrectomyimmunotherapyIVC tumour thrombuskidney cancermetastatic renal cell carcinoma

Identifiers

PMID39014977
PMCPMC12415312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.